内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查

2021-08-24 美国预防医学工作组 JAMA

2型糖尿病的筛查

2021年8月，美国预防医学工作组(USPSTF)更新发布了糖尿病前期和2型糖尿病的筛查建议声明，本文是对2015年版USPSTF糖尿病前期和2型糖尿病的筛查建议声明的更新。USPSTF专家组建议在3

中文标题：

2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查

英文标题：

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement

发布机构：

美国预防医学工作组

发布日期：

2021-08-24

简要介绍：

2021年8月，美国预防医学工作组(USPSTF)更新发布了糖尿病前期和2型糖尿病的筛查建议声明，本文是对2015年版USPSTF糖尿病前期和2型糖尿病的筛查建议声明的更新。USPSTF专家组建议在35-70岁超重或肥胖人群进行糖尿病前期和2型糖尿病筛查。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e8c4f1c002222019, title=2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查, enTitle=Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement, guiderFrom=JAMA, authorId=0, author=, summary=2021年8月，美国预防医学工作组(USPSTF)更新发布了糖尿病前期和2型糖尿病的筛查建议声明，本文是对2015年版USPSTF糖尿病前期和2型糖尿病的筛查建议声明的更新。USPSTF专家组建议在3, cover=https://img.medsci.cn/20211021/1634793019066_1608702.png, journalId=0, articlesId=null, associationId=121, associationName=美国预防医学工作组, associationIntro=由预防和循证医学的非联邦专家和初级保健提供者（如内科，儿科医生，家庭医生，妇科/产科医生，护士和健康行为专家）组成的非联邦小组。为初级保健医生和卫生系统提供指导意见和科学证据。, copyright=0, guiderPublishedTime=Tue Aug 24 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，美国预防医学工作组(USPSTF)更新发布了糖尿病前期和2型糖尿病的筛查建议声明，本文是对2015年版USPSTF糖尿病前期和2型糖尿病的筛查建议声明的更新。USPSTF专家组建议在35-70岁超重或肥胖人群进行糖尿病前期和2型糖尿病筛查。</span></p>, tagList=[TagDto(tagId=116280, tagName=2型糖尿病的筛查)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=21042, guiderKeyword=2型糖尿病筛查, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3793, appHits=257, showAppHits=0, pcHits=511, showPcHits=3535, likes=1, shares=15, comments=7, approvalStatus=1, publishedTime=Thu Oct 21 13:23:23 CST 2021, publishedTimeString=2021-08-24, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Oct 21 13:13:30 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 14:55:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查.pdf)])
2021 USPSTF建议声明：糖尿病前期和2型糖尿病的筛查.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195493, encodeId=207e1195493fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f8d6513459, createdName=ms2000001124316917, createdTime=Sun Feb 20 22:50:21 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193687, encodeId=c340119368ead, content=学习新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185155, encodeId=f2c21185155c3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=559a5712711, createdName=Celine5, createdTime=Mon Jan 17 11:45:40 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180869, encodeId=9246118086982, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Wed Jan 05 14:39:55 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179992, encodeId=ee0d11e99921b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/glMH9jUOFSicVZfoH6IxWOnq1MFHxFYriciaNbOw5tb6iank7G3usciaiaRGicZ8Vz2oQg2rg6hY5ibIsmJ8vPU6j8rUeg/132, createdBy=569b2176786, createdName=12063c92m57暂无昵称, createdTime=Mon Jan 03 13:22:04 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-02-20 ms2000001124316917

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195493, encodeId=207e1195493fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f8d6513459, createdName=ms2000001124316917, createdTime=Sun Feb 20 22:50:21 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193687, encodeId=c340119368ead, content=学习新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185155, encodeId=f2c21185155c3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=559a5712711, createdName=Celine5, createdTime=Mon Jan 17 11:45:40 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180869, encodeId=9246118086982, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Wed Jan 05 14:39:55 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179992, encodeId=ee0d11e99921b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/glMH9jUOFSicVZfoH6IxWOnq1MFHxFYriciaNbOw5tb6iank7G3usciaiaRGicZ8Vz2oQg2rg6hY5ibIsmJ8vPU6j8rUeg/132, createdBy=569b2176786, createdName=12063c92m57暂无昵称, createdTime=Mon Jan 03 13:22:04 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-02-15 1351fc2f66m

    学习新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195493, encodeId=207e1195493fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f8d6513459, createdName=ms2000001124316917, createdTime=Sun Feb 20 22:50:21 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193687, encodeId=c340119368ead, content=学习新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185155, encodeId=f2c21185155c3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=559a5712711, createdName=Celine5, createdTime=Mon Jan 17 11:45:40 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180869, encodeId=9246118086982, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Wed Jan 05 14:39:55 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179992, encodeId=ee0d11e99921b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/glMH9jUOFSicVZfoH6IxWOnq1MFHxFYriciaNbOw5tb6iank7G3usciaiaRGicZ8Vz2oQg2rg6hY5ibIsmJ8vPU6j8rUeg/132, createdBy=569b2176786, createdName=12063c92m57暂无昵称, createdTime=Mon Jan 03 13:22:04 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-17 Celine5

    认真学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195493, encodeId=207e1195493fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f8d6513459, createdName=ms2000001124316917, createdTime=Sun Feb 20 22:50:21 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193687, encodeId=c340119368ead, content=学习新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185155, encodeId=f2c21185155c3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=559a5712711, createdName=Celine5, createdTime=Mon Jan 17 11:45:40 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180869, encodeId=9246118086982, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Wed Jan 05 14:39:55 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179992, encodeId=ee0d11e99921b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/glMH9jUOFSicVZfoH6IxWOnq1MFHxFYriciaNbOw5tb6iank7G3usciaiaRGicZ8Vz2oQg2rg6hY5ibIsmJ8vPU6j8rUeg/132, createdBy=569b2176786, createdName=12063c92m57暂无昵称, createdTime=Mon Jan 03 13:22:04 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-05 坚定的心

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1195493, encodeId=207e1195493fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f8d6513459, createdName=ms2000001124316917, createdTime=Sun Feb 20 22:50:21 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193687, encodeId=c340119368ead, content=学习新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185155, encodeId=f2c21185155c3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=559a5712711, createdName=Celine5, createdTime=Mon Jan 17 11:45:40 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180869, encodeId=9246118086982, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Wed Jan 05 14:39:55 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179992, encodeId=ee0d11e99921b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/glMH9jUOFSicVZfoH6IxWOnq1MFHxFYriciaNbOw5tb6iank7G3usciaiaRGicZ8Vz2oQg2rg6hY5ibIsmJ8vPU6j8rUeg/132, createdBy=569b2176786, createdName=12063c92m57暂无昵称, createdTime=Mon Jan 03 13:22:04 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-03 12063c92m57暂无昵称

    学习

    0

拓展阅读

基层2型糖尿病筛查专家共识

中国医疗保健国际交流促进会 · 2019-07-11

美国预防服务工作组建议声明：儿童和青少年糖尿病前期和2型糖尿病筛查

暂未更新 · 2022-09-13